BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 10856266)

  • 1. Atrial natriuretic peptide is involved in renal actions of moxonidine.
    Mukaddam-Daher S; Gutkowska J
    Hypertension; 2000 Jun; 35(6):1215-20. PubMed ID: 10856266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary responses to acute moxonidine are inhibited by natriuretic peptide receptor antagonist.
    El-Ayoubi R; Menaouar A; Gutkowska J; Mukaddam-Daher S
    Br J Pharmacol; 2005 May; 145(1):50-6. PubMed ID: 15700025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of moxonidine-induced increase in ANP release by atrial hypertrophy.
    Cao C; Kang CW; Kim SZ; Kim SH
    Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H150-6. PubMed ID: 14975931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptors involved in moxonidine-stimulated atrial natriuretic peptide release from isolated normotensive rat hearts.
    Mukaddam-Daher S; Menaouar A; Gutkowska J
    Eur J Pharmacol; 2006 Jul; 541(1-2):73-9. PubMed ID: 16774751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic imidazoline receptor activation in spontaneously hypertensive rats.
    Menaouar A; El-Ayoubi R; Jankowski M; Gutkowska J; Mukaddam-Daher S
    Am J Hypertens; 2002 Sep; 15(9):803-8. PubMed ID: 12219876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of central alpha1-adrenoceptors on renal responses to central moxonidine and alpha-methylnoradrenaline.
    de Andrade CA; de Andrade GM; De Paula PM; De Luca LA; Menani JV
    Eur J Pharmacol; 2009 Apr; 607(1-3):60-7. PubMed ID: 19326476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imidazoline receptors in the heart: a novel target and a novel mechanism of action that involves atrial natriuretic peptides.
    Mukaddam-Daher S; Gutkowska J
    Braz J Med Biol Res; 2004 Aug; 37(8):1239-45. PubMed ID: 15273826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
    Bock C; Niederhoffer N; Szabo B
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonidine and ST-91 may activate imidazoline binding sites in the heart to release atrial natriuretic peptide.
    Mukaddam-Daher S; Lambert C; Gutkowska J
    Hypertension; 1997 Jul; 30(1 Pt 1):83-7. PubMed ID: 9231825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moxonidine into the lateral parabrachial nucleus reduces renal and hormonal responses to cell dehydration.
    Andrade CA; Margatho LO; Andrade-Franzé GM; De Luca LA; Antunes-Rodrigues J; Menani JV
    Neuroscience; 2012 Apr; 208():69-78. PubMed ID: 22373877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imidazoline receptor mediated natriuresis: central and/or peripheral effect?
    Smyth DD; Penner SB
    J Auton Nerv Syst; 1998 Oct; 72(2-3):155-62. PubMed ID: 9851564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central and renal I1 imidazoline preferring receptors: two unique sites mediating natriuresis in the rat.
    Penner SB; Smyth DD
    Cardiovasc Drugs Ther; 1994 Mar; 8 Suppl 1():43-8. PubMed ID: 7915136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism by idazoxan at low dose but not high dose, of the natriuretic action of moxonidine.
    Allan DR; Penner SB; Smyth DD
    Br J Pharmacol; 1996 Jan; 117(1):29-34. PubMed ID: 8825339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the peripheral sympathetic nervous system in the natriuresis following central administration of an I1 imidazoline agonist, moxonidine.
    Penner SB; Smyth DD
    Br J Pharmacol; 1995 Nov; 116(6):2631-6. PubMed ID: 8590981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The peripheral action of clonidine analog ST-91: involvement of atrial natriuretic factor.
    Gutkowska J; Mukaddam-Daher S; Tremblay J
    J Pharmacol Exp Ther; 1997 May; 281(2):670-6. PubMed ID: 9152372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurohumoral mechanism in the natriuretic action of intracerebroventricular administration of renin.
    Zavala L; Barbella Y; Israel A
    J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):39-44. PubMed ID: 15136973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative importance of central imidazoline receptors for the antihypertensive effects of moxonidine and rilmenidine.
    Chan CK; Head GA
    J Hypertens; 1996 Jul; 14(7):855-64. PubMed ID: 8818924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of moxonidine and clonidine on renal function and blood pressure in anesthetized rats.
    Hohage H; Schlatter E; Greven J
    Clin Nephrol; 1997 May; 47(5):316-24. PubMed ID: 9181279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
    Szabo B; Urban R
    Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the natriuretic action of the imidazoline receptor agonist moxonidine by indometacin in the rat.
    Darkwa FK; Smyth DD
    Pharmacology; 1995 Dec; 51(6):347-55. PubMed ID: 8966191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.